Toni K Choueiri Selected Research

Cell-Free Nucleic Acids

3/2022	Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.
12/2021	Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature.
10/2020	Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
1/2020	Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
1/2020	Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toni K Choueiri Research Topics

Disease

349	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 12/2003
263	Neoplasms (Cancer) 04/2024 - 08/2004
71	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 03/2006
43	Carcinoma (Carcinomatosis) 12/2022 - 03/2006
42	Neoplasm Metastasis (Metastasis) 10/2023 - 03/2006
40	Kidney Neoplasms (Kidney Cancer) 01/2024 - 08/2007
25	Disease Progression 11/2023 - 12/2010
25	Fatigue 10/2021 - 06/2008
20	Hypertension (High Blood Pressure) 01/2023 - 06/2008
16	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022 - 08/2008
13	Hypoxia (Hypoxemia) 10/2023 - 10/2006
11	Melanoma (Melanoma, Malignant) 01/2024 - 12/2014
10	COVID-19 08/2023 - 01/2020
8	Brain Neoplasms (Brain Tumor) 03/2024 - 09/2006
7	Adenocarcinoma 11/2022 - 06/2012
7	Breast Neoplasms (Breast Cancer) 05/2014 - 08/2004
6	Hematologic Neoplasms (Hematological Malignancy) 03/2023 - 12/2003
6	Exanthema (Rash) 01/2021 - 08/2004
6	Nausea 01/2021 - 05/2010
6	Diarrhea 01/2021 - 06/2008
6	Anemia 01/2018 - 11/2011
5	Hand-Foot Syndrome 01/2023 - 06/2008
5	Heart Failure 09/2015 - 02/2011
4	Carcinogenesis 11/2023 - 11/2012
4	Body Weight (Weight, Body) 05/2023 - 11/2015
4	Infections 03/2023 - 09/2005
4	Margins of Excision 10/2019 - 11/2011
4	Hypothyroidism 01/2018 - 01/2017
4	Pneumonia (Pneumonitis) 01/2017 - 07/2012
4	Transitional Cell Carcinoma 07/2012 - 04/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2021
3	Sarcoma (Soft Tissue Sarcoma) 02/2024 - 03/2011
3	Venous Thromboembolism 01/2023 - 12/2012

Drug/Important Bio-Agent (IBA)

78	Sunitinib (Sutent)FDA Link 04/2024 - 01/2008
66	Immune Checkpoint InhibitorsIBA 04/2024 - 11/2015
62	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 10/2006
55	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2013
40	NivolumabIBA 01/2024 - 06/2015
37	cabozantinibIBA 08/2023 - 11/2015
32	AndrogensIBA 01/2022 - 03/2009
30	Everolimus FDA Link 01/2023 - 05/2011
28	pembrolizumabIBA 04/2024 - 01/2016
27	Tyrosine Kinase InhibitorsIBA 10/2023 - 01/2008
22	Axitinib (AG 013736)IBA 03/2024 - 06/2008
22	IpilimumabIBA 01/2024 - 01/2017
18	Prostate-Specific Antigen (Semenogelase)IBA 12/2023 - 03/2009
17	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2022 - 10/2009
16	PlatinumIBA 03/2022 - 04/2010
16	pazopanib FDA Link 01/2021 - 03/2011
15	Bevacizumab (Avastin)FDA Link 01/2023 - 05/2009
15	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2006
14	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 11/2012
14	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 01/2008
12	atezolizumabIBA 01/2023 - 01/2018
12	RNA (Ribonucleic Acid)IBA 11/2022 - 07/2014
11	lenvatinibIBA 04/2024 - 03/2019
11	avelumabIBA 02/2024 - 01/2018
11	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2007
11	Hemoglobins (Hemoglobin)IBA 01/2018 - 03/2008
10	B7-H1 AntigenIBA 01/2022 - 07/2014
10	MTOR InhibitorsIBA 01/2022 - 08/2010
10	LigandsIBA 11/2020 - 01/2014
9	TOR Serine-Threonine KinasesIBA 08/2016 - 06/2009
8	Angiogenesis InhibitorsIBA 05/2014 - 10/2006
7	Messenger RNA (mRNA)IBA 10/2021 - 08/2014
7	Phosphotransferases (Kinase)IBA 10/2018 - 06/2008
6	Monoclonal AntibodiesIBA 01/2021 - 11/2015
6	ParaffinIBA 12/2018 - 11/2013
6	Formaldehyde (Formol)FDA Link 12/2018 - 07/2014
5	belzutifanIBA 11/2023 - 01/2021
5	Transcription Factors (Transcription Factor)IBA 11/2023 - 10/2009
5	Cell-Free Nucleic AcidsIBA 03/2022 - 01/2020
5	Alanine Transaminase (SGPT)IBA 01/2022 - 08/2013
5	Lipase (Acid Lipase)FDA Link 01/2021 - 08/2016
5	temsirolimus FDA Link 01/2020 - 05/2009
5	Docetaxel (Taxotere)FDA Link 01/2018 - 07/2011
5	Hormones (Hormone)IBA 01/2015 - 08/2004
4	Carbonic Anhydrase IXIBA 01/2024 - 05/2009
4	Circulating Tumor DNAIBA 11/2023 - 10/2017
4	Oxygen (Dioxygen)IBA 08/2023 - 10/2020
4	vinflunineIBA 01/2017 - 04/2010
3	Programmed Cell Death 1 ReceptorIBA 01/2024 - 02/2018
3	AntigensIBA 01/2024 - 01/2016
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2023 - 02/2012

Therapy/Procedure

291	Therapeutics 04/2024 - 08/2004
45	Immunotherapy 03/2024 - 11/2007
37	Drug Therapy (Chemotherapy) 03/2024 - 03/2006
34	Nephrectomy 10/2023 - 12/2008
20	Prostatectomy (Retropubic Prostatectomy) 10/2019 - 11/2008
17	Radiotherapy 07/2023 - 08/2008
10	Cystectomy 12/2021 - 08/2008
9	Brachytherapy 01/2019 - 10/2010
8	Castration 01/2023 - 10/2009
7	Neoadjuvant Therapy 12/2021 - 10/2012
6	Aftercare (After-Treatment) 08/2023 - 02/2011
6	Metastasectomy 01/2021 - 02/2011
4	Time-to-Treatment 01/2020 - 08/2010
4	Adjuvant Chemotherapy 02/2018 - 07/2014
4	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 05/2007
4	Salvage Therapy 01/2018 - 04/2010